Allen Lutz

Q: What is Allen Lutz's success rate?

Allen Lutz currently has a success rate of 100.

Q: What is the average return of Allen Lutz's calls?

Their stock ratings have generated an average return of 26.454192284933445.

B of A Securities | Healthcare

Allen Lutz is an analyst from B of A Securities specializing in the Healthcare sector. Ranked #692 out of 4570 analysts, they have issued 9 stock ratings with a success rate of 100.00% and an average return of 26.45%.

With 9 ratings to date, Allen Lutz is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 100.00% and an average return of 26.45%, highlighting promising potential as their track record develops further.

#692

Out of 4570

Total Ratings

+100.00%

Success Rate

+26.45%

Average Return

Recent Ratings Analysis

HIMS

Hold

Mar 10, 2026

Target

$23.00

Current

$22.16

Performance

Allen Lutz rated HIMS as Neutral on Mar 10, 2026, setting a price target of 23. The Hold stance appears justified, as shares hovered around 22.16 with a % move.

TDOC

Hold

Nov 25, 2025

Target

$9.00

Current

$5.30

Performance

-28.95%

On Nov 25, 2025, TDOC was given a Neutral rating by Allen Lutz, with a target price of 9. The rating provided protection from downside risk as the stock fell to 5.3.

DOCS

Buy

Oct 27, 2025

Target

$0.00

Current

$25.49

Performance

-62.79%

DOCS received a Buy rating from Allen Lutz on Oct 27, 2025, aiming for null. The rating hasn’t played out as hoped, with the stock trading 62.79% below expectations.

OMI

Sell

Aug 12, 2025

Target

$4.75

Current

$2.68

Performance

-51.01%

On Aug 12, 2025, Allen Lutz published a Underperform outlook on OMI, with a target of 4.75. The Sell recommendation underestimated bullish momentum toward 4.75.

WBA

Sell

Jan 13, 2025

Target

$8.50

Current

$11.98

Performance

0.67%

Allen Lutz on Jan 13, 2025 assigned WBA a Underperform rating, with a price target of 8.5. The bearish stance awaits confirmation while shares hold level at 11.98.

WAY

Buy

Jan 06, 2025

Target

$43.00

Current

$25.88

Performance

-30.99%

On Jan 06, 2025, Allen Lutz reaffirmed WAY with a Buy rating, targeting 43. Shares slid 30.99% despite the recommendation, highlighting downside risks.

OMCL

Hold

Jan 06, 2025

Target

$46.00

Current

$39.83

Performance

-10.91%

OMCL was rated Neutral by Allen Lutz on Jan 06, 2025, with a price objective of 46. Investors who stayed cautious avoided some of the 10.91% decline.

HQY

Buy

Jul 03, 2024

Target

$105.00

Current

$80.04

Performance

-4.21%

On Jul 03, 2024, Allen Lutz initiated coverage on HQY with a Buy rating and target of 105. Neutral price movement of -4.21% leaves room for interpretation.

Frequency Asked Questions

Who is Allen Lutz?

Allen Lutz is an analyst from B of A Securities specializing in the Healthcare sector.

What is Allen Lutz's success rate?

Allen Lutz currently has a success rate of +100.00%.

How many ratings has Allen Lutz issued?

Allen Lutz has issued 9 stock ratings so far.

What is the average return of Allen Lutz's calls?

Their stock ratings have generated an average return of +26.45%.

What is Allen Lutz's ranking?

Allen Lutz is ranked #692 out of 4570 analysts.

What types of ratings does Allen Lutz give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Allen Lutz?

You can follow Allen Lutz by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Allen Lutz?

Their latest rating was a Hold on HIMS issued on 2026-03-10.